Cullinan Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $590.3M | $83.0M |
| FY2025 | — | $408.7M | $88.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $590.3M | $83.0M |
| FY2025 | — | $408.7M | $88.3M |